Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines

Sam R. Telford, Erol Fikrig, Stephen W Barthold, Laura Rosa Brunet, Andrew Spielman, Richard A. Flavell

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Due to local variation in the antigenicity of the agent of Lyme disease (Borrelia burgdorferi), a vaccine derived from any one isolate of this spirochete may fail to protect against the heterogeneous population of organisms that may be present in an enzootic focus. Accordingly, we determined whether antigenically variable spirochetes delivered by naturally infected ticks, collected from a site where transmission is intense, may fail to infect mice actively immunized with recombinant glutathione transferase outer surface fusion proteins A or B (OspA and OspB). Virtually all mice vaccinated by either immunogen appeared not to become infected, as determined by culture or histopathology of their tissues. We conclude that Osp vaccination of mice effectively prevents infection by the agent of Lyme disease in a simulated natural cycle of transmission.

Original languageEnglish (US)
Pages (from-to)755-758
Number of pages4
JournalJournal of Experimental Medicine
Volume178
Issue number2
StatePublished - Aug 1 1993
Externally publishedYes

Fingerprint

Synthetic Vaccines
Borrelia burgdorferi
Spirochaetales
Lyme Disease
Staphylococcal Protein A
Ticks
Glutathione Transferase
Membrane Proteins
Vaccination
Vaccines
Infection
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Telford, S. R., Fikrig, E., Barthold, S. W., Brunet, L. R., Spielman, A., & Flavell, R. A. (1993). Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. Journal of Experimental Medicine, 178(2), 755-758.

Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. / Telford, Sam R.; Fikrig, Erol; Barthold, Stephen W; Brunet, Laura Rosa; Spielman, Andrew; Flavell, Richard A.

In: Journal of Experimental Medicine, Vol. 178, No. 2, 01.08.1993, p. 755-758.

Research output: Contribution to journalArticle

Telford, SR, Fikrig, E, Barthold, SW, Brunet, LR, Spielman, A & Flavell, RA 1993, 'Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines', Journal of Experimental Medicine, vol. 178, no. 2, pp. 755-758.
Telford, Sam R. ; Fikrig, Erol ; Barthold, Stephen W ; Brunet, Laura Rosa ; Spielman, Andrew ; Flavell, Richard A. / Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. In: Journal of Experimental Medicine. 1993 ; Vol. 178, No. 2. pp. 755-758.
@article{432796ac97ca40a1afa6354520124b50,
title = "Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines",
abstract = "Due to local variation in the antigenicity of the agent of Lyme disease (Borrelia burgdorferi), a vaccine derived from any one isolate of this spirochete may fail to protect against the heterogeneous population of organisms that may be present in an enzootic focus. Accordingly, we determined whether antigenically variable spirochetes delivered by naturally infected ticks, collected from a site where transmission is intense, may fail to infect mice actively immunized with recombinant glutathione transferase outer surface fusion proteins A or B (OspA and OspB). Virtually all mice vaccinated by either immunogen appeared not to become infected, as determined by culture or histopathology of their tissues. We conclude that Osp vaccination of mice effectively prevents infection by the agent of Lyme disease in a simulated natural cycle of transmission.",
author = "Telford, {Sam R.} and Erol Fikrig and Barthold, {Stephen W} and Brunet, {Laura Rosa} and Andrew Spielman and Flavell, {Richard A.}",
year = "1993",
month = "8",
day = "1",
language = "English (US)",
volume = "178",
pages = "755--758",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines

AU - Telford, Sam R.

AU - Fikrig, Erol

AU - Barthold, Stephen W

AU - Brunet, Laura Rosa

AU - Spielman, Andrew

AU - Flavell, Richard A.

PY - 1993/8/1

Y1 - 1993/8/1

N2 - Due to local variation in the antigenicity of the agent of Lyme disease (Borrelia burgdorferi), a vaccine derived from any one isolate of this spirochete may fail to protect against the heterogeneous population of organisms that may be present in an enzootic focus. Accordingly, we determined whether antigenically variable spirochetes delivered by naturally infected ticks, collected from a site where transmission is intense, may fail to infect mice actively immunized with recombinant glutathione transferase outer surface fusion proteins A or B (OspA and OspB). Virtually all mice vaccinated by either immunogen appeared not to become infected, as determined by culture or histopathology of their tissues. We conclude that Osp vaccination of mice effectively prevents infection by the agent of Lyme disease in a simulated natural cycle of transmission.

AB - Due to local variation in the antigenicity of the agent of Lyme disease (Borrelia burgdorferi), a vaccine derived from any one isolate of this spirochete may fail to protect against the heterogeneous population of organisms that may be present in an enzootic focus. Accordingly, we determined whether antigenically variable spirochetes delivered by naturally infected ticks, collected from a site where transmission is intense, may fail to infect mice actively immunized with recombinant glutathione transferase outer surface fusion proteins A or B (OspA and OspB). Virtually all mice vaccinated by either immunogen appeared not to become infected, as determined by culture or histopathology of their tissues. We conclude that Osp vaccination of mice effectively prevents infection by the agent of Lyme disease in a simulated natural cycle of transmission.

UR - http://www.scopus.com/inward/record.url?scp=0027292455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027292455&partnerID=8YFLogxK

M3 - Article

C2 - 8340764

AN - SCOPUS:0027292455

VL - 178

SP - 755

EP - 758

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -